Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of β-catenin in proliferation and differentiation

Developmental Biology

Volumn 301, Issue 1, 2007, Pages 298-308

  Liu, Bo ^a   Yu, Hsiao Man Ivy ^a   Hsu, Wei ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Axin; BMP; Craniofacial morphogenesis; Craniosynostosis; Development abnormalities; Skull; Suture; Wnt; catenin

Indexed keywords

AXIN; AXIN 2 PROTEIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CYCLIN D1;

ARTICLE; BONE DEFECT; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL INTERACTION; CELL JUNCTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CRANIOFACIAL SYNOSTOSIS; FEEDBACK SYSTEM; GENE DISRUPTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MATURATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SKULL SUTURE;

EID: 33845625248     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2006.10.018     Document Type: Article

References (59)

1. Akiyama H., et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18 (2004) 1072-1087
2. Akiyama H., et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14665-14670
3. Andl T., et al. Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development. Development 131 (2004) 2257-2268
4. Behrens J., et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280 (1998) 596-599
5. Bennett C.N., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3324-3329
6. Bienz M. beta-catenin: a pivot between cell adhesion and Wnt signalling. Curr. Biol. 15 (2005) R64-R67
7. Bilezikian J.P., et al. Principles of Bone Biology (2002), Academic Press, San Diego
8. Brault V., et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128 (2001) 1253-1264
9. Brembeck F.H., et al. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev. 18 (2004) 2225-2230
10. Canalis E., et al. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev. 24 (2003) 218-235
11. Cohen M.M., and MacLean R.E. Craniosynostosis: Diagnosis, Evaluation, and Management (2000), Oxford Univ. Press, New York
12. Day T.F., et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8 (2005) 739-750
13. de Vries W.N., et al. Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis 26 (2000) 110-112
14. Feng X.H., and Derynck R. Specificity and versatility in TGF-signaling through smads. Annu. Rev. Cell Dev. Biol. 21 (2005) 659-693
15. Ferrari S.L., et al. A role for N-cadherin in the development of the differentiated osteoblastic phenotype. J. Bone Miner. Res. 15 (2000) 198-208
16. Francis-West P., et al. Signalling interactions during facial development. Mech. Dev. 75 (1998) 3-28
17. Gazzerro E., et al. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest. 102 (1998) 2106-2114
18. Glass II D.A., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8 (2005) 751-764
19. Gong Y., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107 (2001) 513-523
20. Gottardi C.J., and Gumbiner B.M. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J. Cell Biol. 167 (2004) 339-349
21. Gumbiner B.M. Regulation of cadherin-mediated adhesion in morphogenesis. Nat. Rev., Mol. Cell Biol. 6 (2005) 622-634
22. Hall B.K. Bone (1990), Telford Press, Caldwell, NJ
23. Hall F.L., et al. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein. Oncogene 8 (1993) 1377-1384
24. Harris T.J., and Peifer M. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol. 15 (2005) 234-237
25. Hartmann C. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 16 (2006) 151-158
26. Hill T.P., et al. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8 (2005) 727-738
27. Hsu W., et al. Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J. Biol. Chem. 274 (1999) 3439-3445
28. Hsu W., et al. Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J. Cell Biol. 155 (2001) 1055-1064
29. Hu M.C., and Rosenblum N.D. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 132 (2005) 215-225
30. Ito K., et al. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts. Oncogene 18 (1999) 7080-7090
31. Jho E.H., et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22 (2002) 1172-1183
32. Jiang X., et al. Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 241 (2002) 106-116
33. Kawaguchi J., et al. Targeted disruption of cadherin-11 leads to a reduction in bone density in calvaria and long bone metaphyses. J. Bone Miner. Res. 16 (2001) 1265-1271
34. Kii I., et al. Cell-cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondro-lineage. J. Bone Miner. Res. 19 (2004) 1840-1849
35. Kolpakova E., and Olsen B.R. Wnt/beta-catenin-a canonical tale of cell-fate choice in the vertebrate skeleton. Dev. Cell 8 (2005) 626-627
36. Korswagen H.C., et al. Distinct beta-catenins mediate adhesion and signalling functions in C. elegans. Nature 406 (2000) 527-532
37. Le Douarin N., and Kalcheim C. The Neural Crest (1999), Cambridge Univ. Press, Cambridge, UK
38. Li X., et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat. Genet. 37 (2005) 945-952
39. Little R.D., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70 (2002) 11-19
40. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
41. Lukas C., et al. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies. Hybridoma 18 (1999) 225-234
42. Marambaud P., et al. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21 (2002) 1948-1956
43. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998) 753-791
44. Massague J., et al. Smad transcription factors. Genes Dev. 19 (2005) 2783-2810
45. Moon R.T., et al. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev., Genet. 5 (2004) 691-701
46. Muenke M., and Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11 (1995) 308-313
47. Ornitz D.M., and Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16 (2002) 1446-1465
48. Panda D.K., et al. The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J. Biol. Chem. 276 (2001) 41229-41236
49. Riethmacher D., et al. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 855-859
50. Sahar D.E., et al. Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev. Biol. 280 (2005) 344-361
51. Soshnikova N., et al. Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb. Genes Dev. 17 (2003) 1963-1968
52. Stains J.P., and Civitelli R. Cell-cell interactions in regulating osteogenesis and osteoblast function. Birth Defects Res. C. Embryo Today 75 (2005) 72-80
53. Warren S.M., et al. The BMP antagonist noggin regulates cranial suture fusion. Nature 422 (2003) 625-629
54. Whitman M., and Raftery L. TGFbeta signaling at the summit. Development 132 (2005) 4205-4210
55. Wilkie A.O., and Morriss-Kay G.M. Genetics of craniofacial development and malformation. Nat. Rev., Genet. 2 (2001) 458-468
56. Yu H.M., et al. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132 (2005) 1995-2005
57. Yu H.M., et al. Development of a unique system for spatiotemporal and lineage-specific gene expression in mice. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8615-8620
58. Yu, H. M., et al., in press. Impaired neural development caused by inductible expression of Axin in transgenic mice. Mech. Dev. doi:10.1016/j.mod.2006.10.002.
59. Zeng L., et al. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90 (1997) 181-192